Gujarat requires a focus on better higher education and greater public acceptability to make biotechnology sector more vibrant and attract more investment in this sector, noted a top government functionary at the 6th edition of BioInvest 2010 in Ahmedabad on Wednesday.
Even as Gujarat has evolved itself as a preferred destination for pharmaceuticals and R&D activities, the state is said to be lagging behind in providing quality human resource for the biotechnology sector.
"Gujarat has a huge potential for developing biotechnology industry in the state, but the state has much to do for improving higher education, which will further open investment avenues in this sector," said Dr M K Bhan, secretary, Department of Biotechnology (DBT), Government of India.
Bhan noted that Gujarat stands at fifth position with respect to the development of biotechnology industry among other states of the country. "Gujarat stands fifth, while states like Tamil Nadu, Karnataka, Andhra Pradesh are doing fairly good among other states,” he told reporters on the sidelines of the conference today.
"In states like Andhra Pradesh and Karnataka, the innovation machinery is good, while Gujarat is good in manufacturing. So, in order to bring more innovation to this sector there is a need to make 2-3 universities here that has its focus on life sciences. Gujarat can do better in higher education but the State lags entrepreneurship in higher education," stated Bhan.
Ravi Saxena, additional chief secretary, Department of Science & Technology, government of Gujarat maintained that Gujarat holds strong base in industries like pharmaceutical, chemicals, and food and beverages, which would provide an ideal ecosystem for the development of the biotech industry in the state.
"With the current landscape already comprising of more than 127 Biotechnology companies and many support organisations, the government is committed to develop the biotech sector in Gujarat in a holistic way, by creating not only a conducive environment, but also providing good infrastructure and support," Saxena added. Commenting about the fresh project proposals from Gujarat, Bhan stated that the state was slow in sending project proposals in the biotech sector.
However, Gujarat already has Ahmedabad and Vadodara as prominent biotech clusters having presence of some of the notable companies including Veeda Research, Lambda Therapeutics besides several others.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
